News | July 03, 2012

Abbreviated ECHO/ECG Protocol Might Protect Young Athletes

July 3, 2012 — While rare, when sudden cardiac death occurs in a seemingly healthy competitive young athlete, the societal loss is high. At a time when the world is battling obesity in epidemic proportions, fear should not affect how parents view athletic participation. A recent study, to be presented at the American Society of Echocardiography (ASE) 23rd Annual Scientific Sessions, June 27 to July 3, 2012, at the Gaylord National in National Harbor, Md., suggests an abbreviated echocardiographic profile may potentially help identify young athletes at risk for sudden cardiac death and to help athletes, their physicians and families make better decisions about full participation in athletic activities. A poster based on the study was displayed July 1. 

“The primary causes of sudden cardiac death are anatomic anomalies, and abnormalities of the muscular and electrical systems. Present athletic screening involves the taking of a thorough personal and family history, physical examination, and, if indicated, further cardiac testing. While ideal, the addition of EKG and echocardiography to every screening examination is extremely time-consuming and is currently cost-prohibitive. In our study, we designed a protocol which allows a less costly, abbreviated echocardiogram as well as EKG in a mass screening scenario. The goal is to provide more a more complete data set which is cost-effective to care providers, who may then better counsel athletes and their families on full participation in sports. While the cost-effectiveness and impact on the rate reduction of sudden cardiac death are not yet known, the impact on quality of life in reassurance of cardiac health during exercise is priceless,” said Michelle A. Grenier, lead investigator on the study. Robert Hinton, Timothy J. Knilans, John L. Jefferies, Wayne Mays, Nicholas Edwards, Jeffrey Towbin, Richard Czosek, and Jeffery Anderson, all of Cincinnati Children’s Hospital Medical Center in Cincinnati, Ohio, were also part of the research team.

The study found that the number of patients with clinically silent aortopathy and myocardial abnormalities appears disproportionately high in these active athletic adolescents. The abbreviated echo format allows for rapid screening of athletes as part of a general sports screening. The impact of early identification and intervention strategies, as well as screening of at risk, first-degree relatives, is not known, but suggests the utility of echo in detecting aortic and myocardial pathology. The risk of these abnormalities having gone undetected is not known. 
 


Related Content

News | Cardiovascular Clinical Studies

April 24, 2024 —Hello Heart, a digital leader in preventive heart health, today announced results from its latest study ...

Home April 24, 2024
Home
News | Cardiovascular Clinical Studies

April 22, 2024 — Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, welcomes the ...

Home April 22, 2024
Home
News | Cardiovascular Clinical Studies

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

Home April 16, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Using a web application to qualify individuals for treatment with a nonprescription statin closely ...

Home April 09, 2024
Home
Subscribe Now